FDA Clears Two Biomarker Assays for Early Alzheimer's Detection
The FDA approved two assays that reliably measure two biomarkers of Alzheimer’s disease. It measures cerebrospinal fluid (CSF) — beta-amyloid and tau proteins.
Roche's Elecsys beta-amyloid (1-42) CSF II and Elecsys phospho-tau (181P) CSF assays are to only be used in those 55 and older who are being evaluated for cognitive difficulties.
The Elecsys AD CSF…